Hansoh Pharmaceutical Group dividend and valuation
Valuation
Hansoh Pharmaceutical Group paid $0.49 per share in dividends over the last 12 months (yield 1.5%). Last ex-dividend date: September 22, 2026. The P/E ratio is 27.6. The average price target of 23 analysts is $48.44.
Data as of November 17, 2026
Hansoh Pharmaceutical Group compared with similar companies
Hansoh Pharmaceutical Group's P/E (trailing 12 months): 27.6, −23% against the median of a group of 11 similar companies (35.9).
| Metric | Hansoh Pharmaceutical Group | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 27.6 | 35.9 | 23.5 – 69.1 | Middle |
| Forward P/E | 24.8 | 29.6 | 20.9 – 41.5 | Middle |
| EV/EBITDA | 26.9 | 26.9 | 17.8 – 43.4 | Middle |
| Price/book | 4.57 | 4.74 | 3.41 – 11.4 | Middle |
| Price/sales | 12.7 | 9.71 | 4.11 – 14.7 | Middle |
| Gross margin | 90.5% | 75.9% | 61.9% – 84.0% | High |
| Operating margin | 37.3% | 27.4% | 22.7% – 33.9% | High |
| Net margin | 42.0% | 27.0% | 15.5% – 33.2% | High |
| ROE | 19.4% | 15.7% | 14.3% – 20.7% | Middle |
| Debt/equity | 0.11 | 0.11 | 0.02 – 0.41 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $202.62B
- Enterprise value
- $169.47B
- PEG
- 2.22
- EV/revenue
- 10.7
Profitability and growth
- ROA
- 9.1%
- ROIC
- 109.0%
- Revenue growth (year over year)
- 11.7%
- Earnings growth (year over year)
- 33.2%
Financial health
- Total cash
- $37.38B
- Total debt
- $4.23B
- Current ratio
- 4.88
- Quick ratio
- 4.78
- Altman Z-Score
- 15.5
- Piotroski F-Score
- 3.00
Dividends
- Annual dividend per share
- $0.49
- Dividend yield
- 1.5%
- Payout ratio
- 40.1%
- Ex-dividend date
- September 22, 2026
Analysts and estimates
- Average price target
- $48.44
- Median price target
- $48.83
- High price target
- $55.50
- Low price target
- $43.02
- Analysts with a price target
- 23
- Consensus
- Strong buy
- Forward EPS
- $1.35
- EPS estimate, current year
- $1.08
Shares and trading
- Beta
- 0.54
- Average volume
- 10.95M
- Shares outstanding
- 6.06B
- Float
- 1.25B
- Institutional ownership
- 12.8%
- Insider ownership
- 79.6%
